ALEXANDER J. DENNER, PH.D. - Corporate Board Profile

BIOGEN INC.

Filing Date	Source Excerpt
2014-04-30	Alexander J. Denner, Ph.D. Age: 44 Director since: 2009 Committee Memberships: Compensation and Management Development, Corporate Governance
2015-04-30	Alexander J. Denner, Ph.D. Age: 45 Committee Memberships: Corporate Governance (Chair), Finance, Risk Dr. Denner has served as one of our directors since 2009.
2016-04-15	Dr. Denner, 46, has served as one of our directors since 2009. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP. Sarissa Capital focuses on improving the strategies of companies to better provide stockholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital. Prior to that, he served as a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management. Dr. Denner has significant experience overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge. Biogen Committee Memberships: Corporate Governance (Chair), Finance. 2015 Director Compensation: $413,508.
2017-04-26	Dr. Denner, 47, has served as one of our directors since 2009. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP. Sarissa Capital focuses on improving the strategies of companies to better provide shareholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital. Prior to that, he served as a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management. Dr. Denner has significant experience overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge. Biogen Committee Memberships: Corporate Governance (Chair), Finance. 2016 Director Compensation: $442,920.
2018-04-27	Dr. Denner, 48, has served as one of our directors since 2009. Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP, a registered investment advisor, which he founded in 2012. Sarissa Capital focuses on improving the strategies of companies to enhance stockholder value. From 2006 to 2011, Dr. Denner served as a Senior Managing Director at Icahn Capital. Prior to that, he served as a portfolio manager at Viking Global Investors, a private investment fund, and Morgan Stanley Investment Management, a global asset management firm. Dr. Denner is also a director of The Medicines Company, a biopharmaceutical company. Dr. Denner has significant experience overseeing the operations and research and development of healthcare companies and evaluating corporate governance matters. He also has extensive experience as an investor, particularly with respect to healthcare companies, and possesses broad healthcare industry knowledge. Biogen Committee Memberships: Corporate Governance (Chair), Finance. 2017 Director Compensation: $420,479.
2019-04-30	Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP, a registered investment advisor, which he founded in 2012. Sarissa Capital focuses on improving the strategies of companies to enhance stockholder value. From 2006 to 2011 Dr. Denner served as a Senior Managing Director at Icahn Capital L.P. Prior to that, he served as a portfolio manager at Viking Global Investors, a private investment fund, and Morgan Stanley Investment Management, a global asset management firm. Dr. Denner also serves as a director of The Medicines Company, a biopharmaceutical company, where he is Chairman of the Board.
2020-04-20	Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP... Biogen Board Committee: Corporate Governance (Chair)... 2019 Director Compensation: Alexander J. Denner total $422,643.
2021-04-23	Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP... Biogen Board Committee: Corporate Governance (Chair)... 2020 Director Compensation: Alexander J. Denner total $439,314.
2022-04-29	Dr. Denner is a founding partner and Chief Investment Officer of Sarissa Capital Management LP... Biogen Board Committee: Corporate Governance (Chair)... 2021 Director Compensation: Alexander J. Denner Fees Earned or Paid in Cash $155,000, Stock Awards $270,413, Total $425,413.
2023-04-28	Alexander J. Denner, Ph.D. Director Since: 2009 Age: 53 Biogen Board Committee: Corporate Governance (Chair) 2022 Director Compensation Table: Alexander J. Denner Fees Earned or Paid in Cash: $155,000 Stock Awards: $270,246 Total: $425,246